Affinage

MED22

Mediator of RNA polymerase II transcription subunit 22 · UniProt Q15528

Length
200 aa
Mass
22.2 kDa
Annotated
2026-06-10
28 papers in source corpus 12 papers cited in narrative 13 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 6/6 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

MED22 (SRB6/SURF5) is an essential, conserved subunit of the Mediator head module that couples gene-specific and general transcriptional machinery to RNA polymerase II (PMID:8324825, PMID:8187178, PMID:23123849). It was first identified genetically as a suppressor of CTD truncation mutations and biochemically as part of an SRB-TBP complex tightly bound to Pol II that binds the CTD and is required for transcription of most class II genes (PMID:8324825, PMID:9671455). Within Mediator, MED22 contributes to activated transcription, enhances TFIIH-dependent CTD phosphorylation, and resides in the head module where its functionally important interaction with Med11 drives recruitment of TFIIH, TFIIE, and Pol II to the preinitiation complex and supports CTD serine 5 phosphorylation (PMID:8187178, PMID:18691966). Crystallography of the fission yeast head module places MED22 within a conserved architecture whose elements contact the rest of Mediator (PMID:23123849). Its requirement is gene-selective rather than universal: a subset of yeast genes is transcribed independently of SRB6, indicating parallel activation pathways (PMID:9620805). In metazoans MED22 is recruited by cell-type-specific co-activators — it binds the tMAC component Topi and, with bromodomain proteins, drives the spermatocyte transcriptional program required for meiosis and male fertility in Drosophila (PMID:26624996, PMID:28235844) — and its podocyte-specific loss in mice causes progressive glomerular disease and renal failure, establishing an indispensable role in transcriptional homeostasis of differentiated cells (PMID:33208756).

Mechanistic history

Synthesis pass · year-by-year structured walk · 9 steps
  1. 1993 High

    Established SRB6/MED22 as a CTD-linked transcription factor by showing it suppresses CTD truncation defects and co-purifies with Pol II in a CTD-binding SRB-TBP complex.

    Evidence Genetic suppressor screen, biochemical co-purification, CTD-binding and in vitro transcription assays in yeast

    PMID:8324825

    Open questions at the time
    • Did not define MED22's position within a discrete complex
    • No direct binding partners within the complex identified
  2. 1994 High

    Placed MED22 as a subunit of the ~20-protein Mediator complex that enables activated transcription and enhances CTD phosphorylation, defining its functional context.

    Evidence Mediator purification, reconstituted in vitro transcription with homogeneous factors, immunological identification in yeast

    PMID:8187178

    Open questions at the time
    • Direct interaction partners within Mediator not resolved
    • Architectural placement within the complex unknown
  3. 1998 Medium

    Defined MED22 as essential for transcription of most class II genes and placed it in the Srb4 functional pathway, while a parallel study showed certain genes are transcribed independently of SRB6, revealing distinct activation routes.

    Evidence Dominant/dosage suppressor genetics with srb4-ts, physical interaction assays, and ts-srb6 mutant analysis with targeted protein destruction in vivo

    PMID:9620805 PMID:9671455

    Open questions at the time
    • Molecular basis of the Srb4-Srb6 interaction not structurally defined
    • Features distinguishing Srb6-dependent from independent genes unknown
  4. 2003 Medium

    Demonstrated conservation by identifying a mammalian MED22 orthologue as a bona fide Mediator subunit and mapping its direct pairwise binding partners, extending the architectural model to mammals.

    Evidence Tandem MS of purified rat liver Mediator plus direct pairwise binding assays

    PMID:12584197

    Open questions at the time
    • Functional consequences of the mammalian interactions not tested
    • No in vivo phenotype established at this stage
  5. 2008 High

    Resolved MED22's mechanistic role by showing the Med11-Med22 head-module interaction drives genome-wide recruitment of TFIIH, TFIIE, and Pol II and supports CTD Ser5 phosphorylation.

    Evidence Interaction-impairing yeast mutants, ChIP-on-chip promoter occupancy, CTD phosphorylation assays

    PMID:18691966

    Open questions at the time
    • Structural basis of differential GTF recruitment not defined
    • Whether this mechanism operates identically in metazoans untested
  6. 2012 High

    Provided the structural placement of MED22 within the conserved head module and validated functional elements required for transcription.

    Evidence X-ray crystallography of S. pombe head module at 3.4 Å with in vitro transcription validation

    PMID:23123849

    Open questions at the time
    • MED22-specific contacts with GTFs not visualized in the structure
    • Conformational dynamics during PIC assembly unresolved
  7. 2017 Medium

    Showed metazoan MED22 is recruited by a tissue-specific co-activator (tMAC component Topi) and, with bromodomain proteins, drives a spermatocyte gene program essential for meiosis and fertility.

    Evidence Co-IP in S2 cells, Drosophila germline loss-of-function genetics, comparative microarray epistasis (med22, aly, sa, tBRD mutants)

    PMID:26624996 PMID:28235844

    Open questions at the time
    • Topi-Med22 interaction shown by single Co-IP without reciprocal/structural validation
    • Direct versus indirect target gene effects not separated
  8. 2020 Medium

    Established MED22's indispensable role in maintaining the transcriptional homeostasis of a differentiated mammalian cell type rather than in its initial differentiation.

    Evidence Podocyte-specific conditional Med22 knockout mouse with histology, ultrastructure, and survival analysis

    PMID:33208756

    Open questions at the time
    • Which podocyte target genes fail upon Med22 loss not identified
    • Mechanism linking transcriptional loss to vacuole formation unknown
  9. 2022 Medium

    Revealed that MED22 clusters localize near a target promoter independent of active transcription, distinguishing its behavior from Pol II and BRD4.

    Evidence STREAMING-tag live-cell single-molecule imaging at the Nanog locus in mouse ES cells

    PMID:36539402

    Open questions at the time
    • Functional consequence of transcription-independent localization untested
    • Whether other Mediator subunits behave similarly unknown

Open questions

Synthesis pass · forward-looking unresolved questions
  • How MED22 head-module recruitment is dynamically coordinated with co-activators across transcriptional cycles, and how its loss translates to tissue-specific disease, remains open.
  • No human Mendelian disease link via direct evidence in the corpus
  • Mechanism of transcription-independent promoter residence undefined
  • Tissue-specific target gene dependencies uncharacterized

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0140110 transcription regulator activity 3 GO:0060090 molecular adaptor activity 2
Localization
GO:0005634 nucleus 3 GO:0005654 nucleoplasm 1
Pathway
R-HSA-74160 Gene expression (Transcription) 3
Partners
MED11MED14MED17TOPI
Complex memberships
Mediator complexMediator head moduleRNA polymerase II holoenzyme

Evidence

Reading pass · 13 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
1993 SRB6 (MED22) is a component of a high molecular weight multisubunit complex tightly bound to RNA polymerase II that also contains SRB2, SRB4, SRB5, and TATA-binding protein (TBP); this SRB-TBP complex binds specifically to recombinant CTD protein, and SRB6 was identified as a suppressor of CTD truncation mutations, placing it functionally in CTD-dependent transcription. Genetic suppressor screen (extragenic suppressors of CTD truncation mutants), biochemical co-purification, CTD-binding assay, in vitro transcription Cell High 8324825
1994 SRB6 (MED22) is one of ~20 polypeptides comprising the yeast Mediator complex; Mediator enables activated transcription, confers greater basal transcription activity, and enhances CTD phosphorylation by TFIIH-associated CTD kinase, indicating a Mediator-CTD interaction. SRB6 was identified as a cross-reactive component of the holoenzyme form of RNA polymerase II. Biochemical purification of Mediator from yeast, reconstituted in vitro transcription with homogeneous factors, immunological identification with antisera against SRB6 Cell High 8187178
1998 SRB6 (MED22) is an essential component of the RNA polymerase II holoenzyme required for transcription of most class II genes; it physically interacts with Srb4, and dominant mutations in SRB6 suppress a temperature-sensitive srb4 mutation, placing SRB6 in the same functional pathway as Srb4 in transcription activation. Dominant suppressor genetics (dosage suppression of srb4-ts), physical interaction assay (genetic and biochemical evidence of interaction with Srb4) Molecular and cellular biology Medium 9671455
1998 Transcription of certain genes in yeast is independent of Srb4 and Srb6 (MED22), demonstrating that the Mediator/CTD-associated pathway is not universally required and that at least two distinct transcriptional activation pathways exist in vivo. Temperature-sensitive srb6 mutant analysis combined with copper-inducible targeted protein destruction, gene-specific transcription assays in vivo Nature Medium 9620805
2003 A mammalian homologue of yeast Srb6 (now MED22) was identified as a bona fide subunit of the mammalian Mediator complex purified from rat liver nuclei; direct pairwise binding partners of MED22 among known mammalian Mediator subunits were identified, contributing to the architectural model of mammalian Mediator. Tandem mass spectrometry of purified mammalian Mediator fractions, direct pairwise binding assays among Mediator subunits The Journal of biological chemistry Medium 12584197
2008 Med22 (MED22) is a subunit of the Mediator head module; interactions between Med11 and Med22 within the head module are functionally important for recruitment of TFIIH, TFIIE, and RNA Pol II to the preinitiation complex (PIC). Impairing the Med11-Med22 interaction differentially affects occupancy of these general transcription factors at promoters genome-wide, and reduces Pol II CTD serine 5 phosphorylation. Yeast genetics (mutant alleles impairing specific protein-protein interactions), ChIP-on-chip genome-wide promoter occupancy assays, Pol II CTD phosphorylation assays Molecular cell High 18691966
2012 Med22 (MED22) is a conserved subunit of the Mediator head module. Crystal structure of the S. pombe head module at 3.4 Å resolution places Med22 within the head module architecture; the structure reveals high conservation and flexibility, and functional elements including the 'shoulder' contact other parts of Mediator. The joint element of the head module is required for transcription in vitro. X-ray crystallography of fission yeast Mediator head module at 3.4 Å; in vitro transcription assay validating the joint element Nature High 23123849
2015 Drosophila Med22 (MED22) is required for activation of hundreds of new transcripts in the spermatocyte transcriptional program. Med22 binds the testis meiotic arrest complex (tMAC) component Topi when co-expressed in S2 cells, suggesting direct recruitment of Mediator by tMAC. Loss of Med22 function in spermatocytes causes meiosis I maturation arrest and male infertility. Co-immunoprecipitation (Med22 binding to Topi in S2 cells), loss-of-function genetics in Drosophila male germline with fertility and meiosis phenotypic readout, microarray/transcriptomic validation of target genes PLoS genetics Medium 26624996
2017 Drosophila Med22 (MED22) and the bromodomain proteins tBRD-1 and tBRD-2 co-regulate expression of a defined set of genes in primary spermatocytes required for spermatid differentiation, placing Med22 in a sequential regulatory hierarchy involving tMAC, Mediator, and tTAFs. Microarray comparison of mutant gene expression profiles (med22, aly, sa, tBRD-1, tBRD-2 mutants), genetic epistasis analysis Biology open Medium 28235844
2020 Podocyte-specific knockout of Med22 (MED22) in mice does not impair normal podocyte maturation but is critical for maintaining podocyte health; loss of Med22 leads to intracellular vacuole formation, progressive podocyte loss, glomerular disease, and premature death from renal failure, demonstrating an essential role for Mediator complex in kidney podocyte physiology. Conditional (podocyte-specific) Med22 knockout mouse, histological and ultrastructural morphological analyses, survival analysis with defined renal failure phenotype Scientific reports Medium 33208756
2022 MED22 protein clusters tend to localize near the transcription start site of the Nanog gene in mouse embryonic stem cells even in the absence of transcriptional activity, in contrast to RNA Pol II and BRD4 clusters which are enriched proximal to the TSS only when the gene is being transcribed. This was determined using the STREAMING-tag live-cell imaging system. Live-cell single-molecule/cluster imaging (STREAMING-tag system combining MS2, TetO repeats, and intein-based reporter) in mouse embryonic stem cells Nature communications Medium 36539402
1995 The mouse Surf5 protein (encoded by the MED22 alias SURF5) is a small hydrophilic protein of 140 amino acids; subcellular fractionation located it to the soluble fraction of the cytoplasm. Subcellular fractionation of mouse cells Genomics Low 8586415
2024 MED22 shows coordinated temporal activity with SOX2, OCT4, and BRD4 at the Nanog locus in living mouse embryonic stem cells; MED22 clusters are present near the Nanog locus during transcriptional priming and termination phases, consistent with a role in transcriptional re-initiation. Trimodal single-molecule live-cell imaging (STREAMING-tag) measuring SOX2 mobility, Nanog locus diffusion, and real-time mRNA synthesis in mouse ES cells bioRxivpreprint Low

Source papers

Stage 0 corpus · 28 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
1994 A multiprotein mediator of transcriptional activation and its interaction with the C-terminal repeat domain of RNA polymerase II. Cell 947 8187178
1993 A multisubunit complex associated with the RNA polymerase II CTD and TATA-binding protein in yeast. Cell 422 8324825
2008 Mediator-dependent recruitment of TFIIH modules in preinitiation complex. Molecular cell 126 18691966
1998 Transcriptional activation independent of TFIIH kinase and the RNA polymerase II mediator in vivo. Nature 91 9620805
1998 Interplay of positive and negative regulators in transcription initiation by RNA polymerase II holoenzyme. Molecular and cellular biology 90 9671455
2012 Structure of the Mediator head module. Nature 88 23123849
1990 The mouse surfeit locus contains a cluster of six genes associated with four CpG-rich islands in 32 kilobases of genomic DNA. Molecular and cellular biology 59 2300057
1999 The C. elegans homeodomain gene unc-42 regulates chemosensory and glutamate receptor expression. Development (Cambridge, England) 49 10207148
2003 Identification of mammalian Mediator subunits with similarities to yeast Mediator subunits Srb5, Srb6, Med11, and Rox3. The Journal of biological chemistry 48 12584197
2017 C. elegans avoids toxin-producing Streptomyces using a seven transmembrane domain chemosensory receptor. eLife 36 28873053
1998 The human Surfeit locus. Genomics 31 9740673
2022 STREAMING-tag system reveals spatiotemporal relationships between transcriptional regulatory factors and transcriptional activity. Nature communications 26 36539402
2015 Recruitment of Mediator Complex by Cell Type and Stage-Specific Factors Required for Tissue-Specific TAF Dependent Gene Activation in an Adult Stem Cell Lineage. PLoS genetics 26 26624996
1997 The comparative genomic structure and sequence of the surfeit gene homologs in the puffer fish Fugu rubripes and their association with CpG-rich islands. Genome research 26 9414319
1993 The organization and conservation of the human Surfeit gene cluster and its localization telomeric to the c-abl and can proto-oncogenes at chromosome band 9q34.1. Human molecular genetics 25 8499913
2018 The effect of childhood trauma on blood transcriptome expression in major depressive disorder. Journal of psychiatric research 24 29975859
2021 Development of a novel lipid metabolism-based risk score model in hepatocellular carcinoma patients. BMC gastroenterology 17 33579192
1995 Surf5: a gene in the tightly clustered mouse surfeit locus is highly conserved and transcribed divergently from the rpL7A (Surf3) gene. Genomics 16 8586415
2000 Isolation and genomic analysis of the human surf-6 gene: a member of the Surfeit locus. Gene 12 10675619
1996 Surfeit locus gene homologs are widely distributed in invertebrate genomes. Molecular and cellular biology 11 8816471
2017 tBRD-1 and tBRD-2 regulate expression of genes necessary for spermatid differentiation. Biology open 10 28235844
2021 CDK7 blockade suppresses super-enhancer-associated oncogenes in bladder cancer. Cellular oncology (Dordrecht, Netherlands) 9 33905040
2002 The human homologue of the mouse Surf5 gene encodes multiple alternatively spliced transcripts. Gene 5 11891058
1996 Tissue-specific processing of the Surf-5 and Surf-4 mRNAs. Gene expression 5 9196076
2023 Proteomics analysis of carotid body tumor revealed potential mechanisms and molecular differences among Shamblin classifications. Experimental biology and medicine (Maywood, N.J.) 3 37845830
2020 Inactivation of mediator complex protein 22 in podocytes results in intracellular vacuole formation, podocyte loss and premature death. Scientific reports 3 33208756
2025 The role of MED22 and its transcriptional interactions with childhood trauma and trauma-focused psychotherapy in patients with major depressive disorder. Biological psychology 0 40250788
2000 [Refined chromosome assignment of human novel H-RalGDS gene on chromosome 9q34.1 by using radiation hybrid genebridge 4 panel]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 0 10653898

Missed literature

Know a paper Affinage missed for MED22? Flag it for the maintainers and the community.

No submissions yet.